At a glance
ClinicalIndex Comparison RecordN/ACompleted· 12 enrolled
Drug / intervention
Cutera truSculptdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Single-center, Prospective, Non-randomized, Open-label Clinical Study to Evaluate the Performance of the truSculpt Radiofrequency Device for Non-invasive Fat Reduction in Abdominal Tissue in Subjects Who Are Scheduled for Abdominoplasty
In Brief
A clinical study evaluating Cutera truSculpt for Body Fat. Completed, enrolled 12 participants across 1 site.
Detailed Summary
Clinical Study to Evaluate the Performance the truSculpt Radiofrequency Device for Lipolysis of Abdominal Fat
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBody Fat
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
Enrollment StartJun 2017
First PostedFeb 2018
Primary CompletionMar 2018
TodayJul 2026
First PostedFeb 14, 2018
Enrollment StartJun 15, 2017
Primary CompletionMar 15, 2018
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 8.4 years ago
Interventions
Cutera truSculptdevice
One truSculpt treatment delivered 0 to 90 days before scheduled Abdominoplasty to one side of the tissue to be removed during abdominoplasty